in situ hybridization; tumor necrosis factor-alpha; thymus; ontogeny; mouse
Abstract :
[en] We have used in situ hybridization to investigate the expression of TNF-alpha genes by thymic cells during fetal development in mice. In 14-day-old fetal thymuses, very scarce cells produce TNF-alpha mRNA. A second phase of cytokine gene expression starts on day 16. The density of positive cells progressively increases up to day 20. Thymuses at 15 days of gestation and after birth do not express detectable cytokine mRNA. In an attempt to identify the nature of the TNF-alpha mRNA-producing cells, acid phosphatase activity, which is characteristic of the macrophage lineage, was studied in the same thymuses. Acid phosphatase-positive cells only appear on day 15. Their frequency increases up to birth. However, no correlation can be established between acid phosphatase--and TNF alpha mRNA--positive cells. The results indicate that a small subset of thymic cells is responsible for TNF-alpha mRNA production during ontogeny: These cells are not yet identified. The possible role of TNF-alpha in thymic ontogeny is discussed.
Broxmeyer H., Williams D., Lu L., Cooper S., Anderson S., Beyer G., Hoffman R., and Rubin B. (1986). The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-Y. J. Immunol. 136: 4487–4495.
Carding S.R., Jenkinson E.J., Kingston R., Bottomly K., and Owen J.J.T. (1989). Developmental control of lymphokine gene expression in fetal thymocytes during T-cell ontogeny. Proc. Natl. Acad. Sci. USA 86: 3342–3345.
Carswell E., Old L., Kassel R., Green S., Fiore N., and Williamson B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72: 3666–3670.
Defresne M.P., Humblet C., Rongy A.M., Greimers R., and Boniver J. (1990). Effect of interferon-gamma and tumor necrosis factor-alpha on lymphoepithelial interactions within thymic nurse cells. Eur. J. Immunol. 20: 429–432.
Duijvestijn A.M., Schutte R., Köhler Y.G., Korn C., and Hoefsmit E.C.M. (1983). Characterization of the population of phagocytic cells in thymic cell suspensions. A morphological and cytochemical study. Cell Tissue Res. 231: 313–324.
Fowlkes B.J., and Pardoll D.M. (1989). Molecular and cellular events of T cell development. Adv. Immunol. 44: 207–264.
Kohase M., Henriksen-DeStefano D., May L., Vilcek J., and Sehgal P. (1986). Induction of β-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 45: 659–666.
Lowenthal J.W., Ballard D.W., Bogerd H., Böhnlein E., and Greene W.C. (1989). Tumor necrosis factor-α activation of the IL-2 receptor-α gene involves the induction of kB-specific DNA binding proteins. J. Immunol. 142: 3121–3128.
Marrack P., Lo D., Brinster R., Palmiter R., Burkly L., Flavell R.H., and Kappler J. (1988). The effect of thymus environment on T cell development and tolerance. Cell 53: 627–634.
Matthews N. (1981). Tumor necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br. J. Cancer 44: 418–424.
Munker R., Gasson J., Ogawa M., and Koeffler H.P. (1986). Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323: 79–82.
Nawroth P., Bank T., Handley D., Cassimeris J., Chess L., and Stern D. (1986). Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1. J. Exp. Med. 163: 1363–1375.
Ranges G.E., Zlotnik A., Espevik T., Dinarello C.A., Cerami A., and Palladino M.A. (1988). Tumor necrosis factor-α /cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines. J. Exp. Med. 167: 1472–1478.
Reem G.H., Duggan A., and Schleuning M. (1989). Immuno-regulation and production of tumor necrosis factor-α by human thymocytes. Cancer Res. 49: 3568–3573.
Suda T., Murray R., Fischer M., Yukota T., and Zlotnik A. (1990a). Tumor necrosis factor-α and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2. J. Immunol. 144:1783–1787.
Suda T., Murray R., Guidos C., and Zlotnik A. (1990b). Growth-promoting activity of IL-1α, IL-6, and tumor necrosis factor-α in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. J. Immunol. 144: 3039–3045.
